Bluebird Bio Inc Quick Ratio (BLUE) starting from the first quarter 2025 to first quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Bluebird Bio Inc   (NASDAQ: BLUE)

Bluebird Bio Inc 's Quick Ratio

BLUE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Bluebird Bio Inc 's Cash & cash equivalent grew by 26.38 % in the Q1 2025 sequentially, while Current Liabilities decreased, this led to improvement in Bluebird Bio Inc 's Quick Ratio to 0.25, Quick Ratio remained below Bluebird Bio Inc average.

Within Biotechnology & Pharmaceuticals industry 113 other companies have achieved higher Quick Ratio than Bluebird Bio Inc in first quarter 2025. While Quick Ratio total ranking has improved so far during the Q1 2025 to 2235, from total ranking in the fourth quarter 2024 at 3253.

Explain Quick Ratio?
How much Cash & cash equivalents BLUE´s has?
What are BLUE´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLUE Quick Ratio (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1
Y / Y Current Liabilities Change 7.33 % 60.64 % 86.23 % 341.87 % 354.95 %
Y / Y Cash & cash equivalent Change -62.86 % -71.9 % -59.46 % -41.27 % -33.37 %
Quick Ratio MRQ 0.25 0.19 0.24 0.48 0.72
BLUE's Total Ranking # 2235 # 3253 # 2443 # 2223 # 1517
Seq. Current Liabilities Change -1.99 % 8.59 % -0.64 % 1.48 % 46.7 %
Seq. Cash & cash equivalent Change 26.38 % -11.81 % -50.96 % -32.06 % -4.38 %



Quick Ratio first quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 114
Healthcare Sector # 640
Overall Market # 2235


Quick Ratio Statistics
High Average Low
28.91 7.37 0.19
(Jun 30 2015)   (Dec 31 2024)




Financial Statements
Bluebird Bio Inc 's Current Liabilities $ 315 Millions Visit BLUE's Balance sheet
Bluebird Bio Inc 's Cash & cash equivalent $ 79 Millions Visit BLUE's Balance sheet
Source of BLUE's Sales Visit BLUE's Sales by Geography


Cumulative Bluebird Bio Inc 's Quick Ratio

BLUE's Quick Ratio for the trailling 12 Months

BLUE Quick Ratio

 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 70.89 % 146.22 % 185.28 % 211.42 % 112.9 %
Y / Y Cash & cash equivalent TTM Growth -58.31 % -49.03 % -29.37 % -14.87 % 10.73 %
Quick Ratio TTM 0.29 0.4 0.6 0.79 1.19
Total Ranking TTM # 3472 # 3312 # 3422 # 1418 # 2985
Seq. Current Liabilities TTM Growth 1.78 % 11.16 % 14.42 % 32.01 % 46.65 %
Seq. Cash & cash equivalent TTM Growth -27.26 % -24.59 % -13.78 % -11.86 % -11.07 %

Quick ratio ranking by company, industry and sector >> Back to BLUE Financial Strength Comparisons >> Go to Compare BLUE Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2025 to $315.08 millions, cumulative Quick Ratio decreased to 0.29 below the Bluebird Bio Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 151 other companies have achieved higher Quick Ratio than Bluebird Bio Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2024 from 3312 to 3472.

Explain Quick Ratio?
How much Cash & cash equivalents BLUE´s has?
What are BLUE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 152
Healthcare Sector # 923
Within the Market # 3472


trailing twelve months Quick Ratio Statistics
High Average Low
18.37 7.15 0.29
(March 31, 2016)   (Mar 31 2025)




Companies with similar Quick Ratio in the quarter ending Mar 31 2025, within Biotechnology & Pharmaceuticals Industry Quick RatioMar 31 2025 MRQ Cash & cash equivalentMar 31 2025 MRQ Current Liabilities
Phoenix Biotech Acquisition Corp  0.66 $ 5.204  Millions$ 7.859  Millions
Valneva Se  0.63 $ 122.808  Millions$ 193.672  Millions
Elutia Inc   0.55 $ 17.358  Millions$ 31.351  Millions
Sangamo Therapeutics Inc   0.51 $ 25.180  Millions$ 49.562  Millions
Mink Therapeutics Inc   0.46 $ 3.235  Millions$ 7.003  Millions
Cellectis S a   0.42 $ 61.533  Millions$ 145.752  Millions
Amgen Inc   0.38 $ 8,810.000  Millions$ 23,008.000  Millions
Intensity Therapeutics Inc   0.35 $ 0.929  Millions$ 2.629  Millions
Dbv Technologies S a   0.33 $ 13.994  Millions$ 42.393  Millions
Coherus Oncology inc   0.32 $ 82.411  Millions$ 255.042  Millions
Outlook Therapeutics Inc   0.31 $ 7.556  Millions$ 24.768  Millions
Biocardia Inc   0.29 $ 0.949  Millions$ 3.234  Millions
Atara Biotherapeutics Inc   0.27 $ 13.841  Millions$ 50.493  Millions
Bluebird Bio Inc   0.25 $ 78.744  Millions$ 315.078  Millions
Redwoods Acquisition Corp  0.24 $ 0.566  Millions$ 2.338  Millions
Aim Immunotech Inc   0.24 $ 2.247  Millions$ 9.533  Millions
Tevogen Bio Holdings Inc   0.23 $ 1.975  Millions$ 8.549  Millions
Aptose Biosciences Inc   0.23 $ 1.300  Millions$ 5.714  Millions
Opthea Limited  0.22 $ 55.630  Millions$ 257.868  Millions
Windtree Therapeutics Inc  0.18 $ 1.173  Millions$ 6.476  Millions
Xtant Medical Holdings Inc   0.17 $ 5.032  Millions$ 28.874  Millions
Zeo Scientifix Inc   0.16 $ 0.542  Millions$ 3.453  Millions
Brainstorm Cell Therapeutics inc   0.15 $ 1.644  Millions$ 10.901  Millions
Alvotech  0.14 $ 172.359  Millions$ 1,262.147  Millions
Vaxart Inc   0.13 $ 13.240  Millions$ 98.504  Millions
Armata Pharmaceuticals Inc   0.11 $ 11.688  Millions$ 110.540  Millions
Tradeup Acquisition Corp  0.10 $ 0.421  Millions$ 4.275  Millions
Agenus Inc  0.09 $ 18.488  Millions$ 208.304  Millions
Ladrx Corporation  0.09 $ 0.207  Millions$ 2.395  Millions
Atlantic Coastal Acquisition Corp Ii  0.06 $ 1.327  Millions$ 20.608  Millions

Date modified: 2026-09-26T07:02:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.